secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phio Pharmaceuticals Corp. (PHIO)
CIK:        0001533040
Form:       8-K
Filed at:   2025-09-15T23:59:59+00:00
Accession:  0001683168-25-006985
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phio stockholders approve 950,000-share increase to 2020 LTIP plan; adopt 3-year say-on-pay frequency
--------------------------------------------------------------------------------

- All six director nominees elected with 84-94% of votes cast; 1,828,465 broker non-votes.
- Grant Thornton ratified as auditor for FY2025 with 2,330,465 votes for, 40,532 against.
- 2020 Plan amendment approved with 387,895 for, 152,069 against; shares available increased to 1,023,017.
- Non-binding say-on-pay passed with 474,987 for (87% of votes cast).
- Stockholders preferred 3-year say-on-pay frequency (276,177 votes); board adopted triennial vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533040/000168316825006985/0001683168-25-006985-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533040/000168316825006985/phio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-006985

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer